Bio-Techne (NASDAQ: TECH) revenue
Bio-Techne reported revenue of $1,215m for fiscal 2026, 0.4% less than in fiscal 2025 ($1,220m). Since fiscal 2017 its revenue has grown by 115.8%, an average growth of 8.9% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $1,215m | −0.4% | $251.9m | 20.7% |
| 2025 | $1,220m | +5.2% | $102.3m | 8.4% |
| 2024 | $1,159m | +2.0% | $206.7m | 17.8% |
| 2023 | $1,137m | +2.8% | $298.9m | 26.3% |
| 2022 | $1,106m | +18.7% | $296.6m | 26.8% |
| 2021 | $931.0m | +26.0% | $237.3m | 25.5% |
| 2020 | $738.7m | +3.5% | $157.4m | 21.3% |
| 2019 | $714.0m | +11.0% | $146.7m | 20.5% |
| 2018 | $643.0m | +14.2% | $136.2m | 21.2% |
| 2017 | $563.0m | — | $120.6m | 21.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Bio-Techne
- How much revenue did Bio-Techne make in fiscal 2026?
- Bio-Techne reported revenue of $1,215m for fiscal 2026, compared with $1,220m in fiscal 2025.
- How much has the revenue of Bio-Techne grown?
- Between fiscal 2017 and fiscal 2026 it went from $563.0m to $1,215m: 115.8% more, an average growth of 8.9% a year.
- What was the best year for revenue at Bio-Techne?
- Of its last 10 fiscal years, fiscal 2025, with $1,220m.
- Where do the figures for Bio-Techne come from?
- From the annual report (Form 10-K) that Bio-Techne files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Bio-Techne files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Bio-Techne: the Bio-Techne page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Bio-Techne by fiscal year, with the filing behind every figure: Bio-Techne dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.